VIVUS Earnings: Here’s Why Investors Don’t Like These Results
VIVUS Inc. (NASDAQ:VVUS) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 5.15%.
VIVUS Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased to $-0.53 in the quarter versus EPS of $-0.20 in the year-earlier quarter.
Revenue: Was the same at $4.11 million as the year-earlier quarter.
Actual vs. Wall St. Expectations: VIVUS Inc. reported adjusted EPS loss of $0.53 per share. By that measure, the company missed the mean analyst estimate of $-0.51. It missed the average revenue estimate of $5.22 million.
Quoting Management: “The FDA’s approval of the REMS modification allowing distribution of Qsymia through certified retail pharmacy locations was a significant achievement in our ongoing efforts to expand access to Qsymia,” stated Leland Wilson, chief executive officer of VIVUS. “We have begun to lay the foundation and our team is working diligently to ensure availability of Qsymia in certified retail pharmacies.”
Key Stats (on next page)…
Revenue increased 108.63% from $1.97 million in the previous quarter. EPS increased to $-0.53 in the quarter versus EPS of $-0.56 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.21 to a loss $0.43. For the current year, the average estimate has moved down from a loss of $1.11 to a loss of $1.67 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)